An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

Trial Profile

An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jun 2018

At a glance

  • Drugs Apremilast (Primary)
  • Indications Plaque psoriasis
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2018 Planned initiation date changed from 1 Apr 2018 to 1 Jun 2018.
    • 27 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top